{
    "2019-09-18": [
        [
            {
                "time": "2018-11-15",
                "original_text": "UPDATE 1-GSK's over-the-counter nicotine oral spray gets FDA panel backing",
                "features": {
                    "keywords": [
                        "GSK",
                        "nicotine",
                        "oral spray",
                        "FDA",
                        "panel backing"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-16",
                "original_text": "Johnson & Johnson to Host Investor Conference Call on Third Quarter Results",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Investor",
                        "Conference Call",
                        "Third Quarter Results"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Establishment Labs Poised to Capitalize on Allergan Breast Implant Issues",
                "features": {
                    "keywords": [
                        "Establishment Labs",
                        "Allergan",
                        "Breast Implant",
                        "Issues"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "Are You Looking for a High-Growth Dividend Stock? Johnson & Johnson (JNJ) Could Be a Great Choice",
                "features": {
                    "keywords": [
                        "High-Growth",
                        "Dividend Stock",
                        "Johnson & Johnson",
                        "JNJ"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}